Company Valuation: GlucoTrack, Inc.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 70.6 63.8 21.57 5.46 5.975 3.524
Change - -9.63% -66.19% -74.69% 9.44% -41.02%
Enterprise Value (EV) 1 61.14 57.99 19.46 1.164 0.6255 -0.4127
Change - -5.16% -66.45% -94.02% -46.27% -165.98%
P/E - - - - - -0.12x
PBR - - - - - 1.25x
PEG - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA -19.8x -14.5x -4.41x -0.16x -0.04x 0.03x
EV / EBIT -19.5x -14.4x -4.39x -0.16x -0.04x 0.03x
EV / FCF -22x -25.6x -9.13x -0.3x -0.08x 0.04x
FCF Yield -4.54% -3.91% -11% -335% -1,326% 2,289%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 - - - - - -936.5
Distribution rate - - - - - -
Net sales - - - - - -
EBITDA 1 -3.085 -3.998 -4.409 -7.091 -14.51 -16.05
EBIT 1 -3.132 -4.04 -4.432 -7.104 -14.55 -16.09
Net income 1 -2.696 -4.067 -4.435 -7.097 -22.6 -19.39
Net Debt 1 -9.46 -5.812 -2.117 -4.296 -5.35 -3.937
Reference price 2 830,603.6500 750,593.9952 253,797.9696 47,069.6234 13,427.9893 116.0999
Nbr of stocks (in thousands) 0.09 0.09 0.09 0.12 0.45 30.4
Announcement Date 13/04/21 31/03/22 31/03/23 28/03/24 31/03/25 30/03/26
1USD in Million2USD
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 225K
17.32x6.64x12.72x1.72% 66.37B
32.67x8.73x28.87x0.07% 58.86B
38.41x6.84x20.46x0.85% 55.22B
44.13x6.17x29.36x-.--% 47.21B
34.55x3.29x14.19x-.--% 42.45B
36.23x8.96x23.37x0.36% 36.44B
-19.98x53.61x-21.71x-.--% 35.19B
41.91x8.08x27.1x-.--% 32.66B
-74.98x14.21x-76.38x-.--% 26.73B
Average 16.70x 12.95x 6.44x 0.33% 40B
Weighted average by Cap. 21.75x 11.52x 11.45x 0.44%

Y-o-Y evolution of P/E

Valuation ratios - P/E - GlucoTrack, Inc.

Historical PBR trend

Valuation ratios - PBR - GlucoTrack, Inc.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - GlucoTrack, Inc.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - GlucoTrack, Inc.

  1. Stock Market
  2. Stocks
  3. GCTK Stock
  4. Valuation GlucoTrack, Inc.